Vueway 485.1 mg/mL (Gadopiclenol INJECTION) 485.1 mg/mL

Vueway 485.1 mg/mL is a gadopiclenol injection used for magnetic resonance imaging (MRI) contrast enhancement. This intravenous solution aids in improving the visibility of internal structures during diagnostic imaging procedures.

Strength

485.1 mg/mL

Pack Size

6 CARTON in 1 CASE (0270-7015-64) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 100 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

BRACCO DIAGNOSTICS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vueway 485.1 mg/mL is primarily used as a contrast agent in MRI scans. It helps to enhance the clarity of images, making it easier for healthcare professionals to detect and evaluate abnormalities. This gadopiclenol injection is often utilized in various diagnostic imaging procedures to improve the visibility of blood vessels, organs, and tissues.

Side Effects

Common effects of Vueway 485.1 mg/mL may include temporary discomfort at the injection site. Some individuals might experience mild nausea or a metallic taste in the mouth. These effects are generally short-lived and resolve quickly after the procedure.

Precautions & Warnings

Vueway 485.1 mg/mL should be administered by healthcare professionals in a controlled setting. Individuals with a history of allergic reactions to contrast agents should inform their healthcare provider before use. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

Vueway 485.1 mg/mL may interact with certain medications or medical conditions. It is important to disclose all current medications and health conditions to your healthcare provider before undergoing an MRI with this contrast agent. Alcohol and other substances should be avoided as they may affect the procedure.

Frequently Asked Questions

Vueway 485.1 mg/mL is used as a contrast agent to enhance the visibility of internal structures during MRI scans.

Vueway 485.1 mg/mL is administered intravenously by healthcare professionals during an MRI procedure.

Common effects may include temporary discomfort at the injection site, mild nausea, or a metallic taste in the mouth.

Individuals with a history of allergic reactions to contrast agents should inform their healthcare provider before use.

It is important to disclose all current medications to your healthcare provider to check for potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.